Healthcare -
Biotechnology - NYSE - DK
$ 78.69
-5.27 %
$ 349 B
Market Cap
26.86
P/E
NVO - REVENUE
Revenue NVO - Novo Nordisk A/S
232 B
LAST VALUE
28.44%
2 YEAR CAGR
15.74%
5 YEAR CAGR
10.76%
10 YEAR CAGR